Lijun Fang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lijun Fang has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Weixian Liu
Department of Oral and Maxillofacial Surgery, Shengjing Hospital of China Medical University, Shenyang, China
2 shared publicationsFangyu Qi
Department of Oral and Maxillofacial Surgery, Shengjing Hospital of China Medical University, Shenyang, China
1 shared publicationGuangping Zhang
Department of Oral and Maxillofacial Surgery, Shengjing Hospital of China Medical University, Shenyang, China
1 shared publicationHao Chen
Department of Oral and Maxillofacial Surgery, Shengjing Hospital of China Medical University, Shenyang Liaoning, China
1 shared publication- Hezi Zhang
Department of Research and Development, Shenzhen Nucleus Gene Technology Co., Ltd., Shenzhen, China
1 shared publication Lichao Cao
Department of Research and Development, Shenzhen Nucleus Gene Technology Co., Ltd., Shenzhen, China
1 shared publication
Latest Publications
- Open Access
- 10 November 2025
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 16, 1650544
Unveiling disulfidptosis-linked lncRNA signatures: insights into the immune microenvironment and drug responsiveness in oral squamous cell carcinoma
Objectives: Oral squamous cell carcinoma (OSCC) has a highly incidence rate and mortality rate all over the world. Hitherto, there are limited studies on survival significance between disulfidptosis-related lncRNAs (DRLs) and OSCC. Therefore, this study was conducted to investigate the potential role of these DRLs and provide some theoretical support in the clinical treatment of OSCC. Methods: OSCC-related lncRNAs and disulfidptosis-related genes (DRGs) were retrieved from public databases. Using Pearson correlation, machine learning, and expression profiling, we identified differentially expressed DRLs (DE-DRLs), developed a DE-DRLs-based risk model and independent prognostic nomogram, performed immunological and tumor microenvironment analyses to explore DE-DRLs regulatory mechanisms, predicted potential drugs for OSCC, and validated bioinformatics findings. Results: In this study, 9 DE-DRLs were identified that correlated with OSCC. The risk model and nomogram showed good clinical utility for assessing the likelihood of OSCC occurrence. Patients exhibiting elevated levels of eosinophils, activated natural killer (NK) cells, or naïve CD4 + T cells experienced significantly poorer overall survival (OS), and patients with high tumor mutational burden (TMB) had worse prognosis. 12 drugs were identified for OSCC treatment, such as BMS-754807_2171 and Foretinib_2040. Conclusion: Our study identified 9 DE-DRLs correlated with OSCC, which will be a personalized prediction tool for prognosis and immune responses in OSCC patients.
- 10 November 2025
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 16, 1650544
Open AccessUnveiling disulfidptosis-linked lncRNA signatures: insights into the immune microenvironment and drug responsiveness in oral squamous cell carcinoma
Objectives: Oral squamous cell carcinoma (OSCC) has a highly incidence rate and mortality rate all over the world. Hitherto, there are limited studies on survival significance between disulfidptosis-related lncRNAs (DRLs) and OSCC. Therefore, this study was conducted to investigate the potential role of these DRLs and provide some theoretical support in the clinical treatment of OSCC. Methods: OSCC-related lncRNAs and disulfidptosis-related genes (DRGs) were retrieved from public databases. Using Pearson correlation, machine learning, and expression profiling, we identified differentially expressed DRLs (DE-DRLs), developed a DE-DRLs-based risk model and independent prognostic nomogram, performed immunological and tumor microenvironment analyses to explore DE-DRLs regulatory mechanisms, predicted potential drugs for OSCC, and validated bioinformatics findings. Results: In this study, 9 DE-DRLs were identified that correlated with OSCC. The risk model and nomogram showed good clinical utility for assessing the likelihood of OSCC occurrence. Patients exhibiting elevated levels of eosinophils, activated natural killer (NK) cells, or naïve CD4 + T cells experienced significantly poorer overall survival (OS), and patients with high tumor mutational burden (TMB) had worse prognosis. 12 drugs were identified for OSCC treatment, such as BMS-754807_2171 and Foretinib_2040. Conclusion: Our study identified 9 DE-DRLs correlated with OSCC, which will be a personalized prediction tool for prognosis and immune responses in OSCC patients.
- Open Access
- 2 July 2025
- Published by Gleam Publishing Company in Journal of Clinical Question
- Vol. 2 (3)
Twin Block Appliance for Postoperative Treatment of Intracapsular Condylar Fracture in a Child: A Case Report
Read the article titled "Twin Block Appliance for Postoperative Treatment of Intracapsular Condylar Fracture in a Child: A Case Report" on Journal of Clinical Question.
- 2 July 2025
- Published by Gleam Publishing Company in Journal of Clinical Question
- Vol. 2 (3)
Open AccessTwin Block Appliance for Postoperative Treatment of Intracapsular Condylar Fracture in a Child: A Case Report
Read the article titled "Twin Block Appliance for Postoperative Treatment of Intracapsular Condylar Fracture in a Child: A Case Report" on Journal of Clinical Question.
- Open Access
- 1 June 2021
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 13, 4709-4723
High SQLE Expression and Gene Amplification Correlates with Poor Prognosis in Head and Neck Squamous Cell Carcinoma
Objective: Squalene epoxidase (SQLE) is considered a metabolic oncogene, but its biological function and prognostic value in head and neck squamous cell carcinoma (HNSCC) remain unclear. We aimed to evaluate the role of SQLE in the occurrence and development of HNSCC through bioinformatics analysis, and validation experiments. Methods: Transcriptomic, genomic, and clinical data from The Cancer Genome Atlas were used for pan-cancer analysis. SQLE expression in HNSCC was evaluated using Gene Expression Omnibus datasets and immunohistochemistry. The biological significance of SQLE in the tumor microenvironment (TME) of HNSCC was determined using TISCH, HuRI, LinkedOmics, and TIMER 2.0. The prognostic value of SQLE in HNSCC was analyzed using univariate Cox regression and Kaplan–Meier survival curves. Effect of SQLE on the Cal27 HNSCC cell line was evaluated using cell counting kit 8, wound healing, and EdU assays. Results: SQLE was overexpressed and amplified in various cancers, including HNSCC. High SQLE expression promoted cell proliferation, associated with T stage in HNSCC patients. Copy number amplification and DNA demethylation contributed to high SQLE expression in HNSCC, which was associated with poor prognosis. SQLE was related to HNSCC TME, and its mRNA expression/copy number alterations were negatively correlated with the infiltration of CD8+ T cells, follicular helper T cells, and regulatory T cell infiltration and mast cell activation and positively correlated with the infiltration of M0 macrophages and resting mast cells in HNSCC. Conclusion: SQLE was identified as a prognostic biomarker and a potential pharmaceutical target for HNSCC.
- 1 June 2021
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 13, 4709-4723
Open AccessHigh SQLE Expression and Gene Amplification Correlates with Poor Prognosis in Head and Neck Squamous Cell Carcinoma
Objective: Squalene epoxidase (SQLE) is considered a metabolic oncogene, but its biological function and prognostic value in head and neck squamous cell carcinoma (HNSCC) remain unclear. We aimed to evaluate the role of SQLE in the occurrence and development of HNSCC through bioinformatics analysis, and validation experiments. Methods: Transcriptomic, genomic, and clinical data from The Cancer Genome Atlas were used for pan-cancer analysis. SQLE expression in HNSCC was evaluated using Gene Expression Omnibus datasets and immunohistochemistry. The biological significance of SQLE in the tumor microenvironment (TME) of HNSCC was determined using TISCH, HuRI, LinkedOmics, and TIMER 2.0. The prognostic value of SQLE in HNSCC was analyzed using univariate Cox regression and Kaplan–Meier survival curves. Effect of SQLE on the Cal27 HNSCC cell line was evaluated using cell counting kit 8, wound healing, and EdU assays. Results: SQLE was overexpressed and amplified in various cancers, including HNSCC. High SQLE expression promoted cell proliferation, associated with T stage in HNSCC patients. Copy number amplification and DNA demethylation contributed to high SQLE expression in HNSCC, which was associated with poor prognosis. SQLE was related to HNSCC TME, and its mRNA expression/copy number alterations were negatively correlated with the infiltration of CD8+ T cells, follicular helper T cells, and regulatory T cell infiltration and mast cell activation and positively correlated with the infiltration of M0 macrophages and resting mast cells in HNSCC. Conclusion: SQLE was identified as a prognostic biomarker and a potential pharmaceutical target for HNSCC.